These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11565958)

  • 1. Inhibition of lung metastases of murine renal cell carcinoma by the combination of radiation and interferon-alpha-producing tumor cell vaccine.
    Nishisaka N; Jones RF; Morse P; Kuratsukuri K; Romanowski R; Wang CY; Haas GP
    Cytokines Cell Mol Ther; 2000 Dec; 6(4):199-206. PubMed ID: 11565958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy for lung metastases of murine renal cell carcinoma: synergy between radiation and cytokine-producing tumor vaccines.
    Nishisaka N; Maini A; Kinoshita Y; Yasumoto R; Kishimoto T; Jones RF; Morse P; Hillman GG; Wang CY; Haas GP
    J Immunother; 1999 Jul; 22(4):308-14. PubMed ID: 10404432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of radiation and vaccination with autologous tumor cells expressing IL-2, IFN-gamma and GM-CSF for treatment of murine renal carcinoma.
    Maini A; Nishisaka N; Kinoshita Y; Jones RF; Wang CY; Haas GP
    In Vivo; 2003; 17(2):119-23. PubMed ID: 12792971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
    Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N
    J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local tumor irradiation augments the response to IL-2 therapy in a murine renal adenocarcinoma.
    Younes E; Haas GP; Dezso B; Ali E; Maughan RL; Kukuruga MA; Montecillo E; Pontes JE; Hillman GG
    Cell Immunol; 1995 Oct; 165(2):243-51. PubMed ID: 7553889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation therapy enhances the therapeutic effect of immunotherapy on pulmonary metastases in a murine renal adenocarcinoma model.
    Chakrabarty A; Hillman GG; Maughan RL; Ali E; Pontes JE; Haas GP
    In Vivo; 1994; 8(1):25-31. PubMed ID: 8054507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of local tumor irradiation combined with interleukin 2 therapy in murine renal carcinoma: histological evaluation of pulmonary metastases.
    Dezso B; Haas GP; Hamzavi F; Kim S; Montecillo EJ; Benson PD; Pontes JE; Maughan RL; Hillman GG
    Clin Cancer Res; 1996 Sep; 2(9):1543-52. PubMed ID: 9816331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo.
    Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH
    Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of retinoic acid and interferon-gamma on expression of the retinoic acid receptor in mouse renal cell carcinoma.
    Hara I; Taguchi I; Miyake H; Hara S; Gotoh A; Kamidono S
    Int J Oncol; 2001 Nov; 19(5):959-62. PubMed ID: 11604994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of irradiated renal carcinoma expressing hepatitis B surface antigen against renal-cell carcinoma-mediated tumors.
    Moon Y; Cho SG; Lee JW; Min WS; Kim CC; Lee HK; Kim YG; Chang HS; Chae HS; Kim HY; Tani K
    Cancer Biother Radiopharm; 2006 Jun; 21(3):211-6. PubMed ID: 16918297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy of radiation therapy and immunotherapy in murine renal cell carcinoma.
    Dybal EJ; Haas GP; Maughan RL; Sud S; Pontes JE; Hillman GG
    J Urol; 1992 Oct; 148(4):1331-7. PubMed ID: 1404669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
    Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
    J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.
    Belldegrun A; Tso CL; Sakata T; Duckett T; Brunda MJ; Barsky SH; Chai J; Kaboo R; Lavey RS; McBride WH
    J Natl Cancer Inst; 1993 Feb; 85(3):207-16. PubMed ID: 8423625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of interferon-alpha A/D in combination with the Japanese and Chinese traditional herbal medicine juzen-taiho-to on lung metastasis of murine renal cell carcinoma.
    Muraishi Y; Mitani N; Yamaura T; Fuse H; Saiki I
    Anticancer Res; 2000; 20(5A):2931-7. PubMed ID: 11062703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium stibogluconate interacts with IL-2 in anti-Renca tumor action via a T cell-dependent mechanism in connection with induction of tumor-infiltrating macrophages.
    Fan K; Zhou M; Pathak MK; Lindner DJ; Altuntas CZ; Tuohy VK; Borden EC; Yi T
    J Immunol; 2005 Nov; 175(10):7003-8. PubMed ID: 16272361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode-of-action, efficacy, and safety of a homologous multi-epitope vaccine in a murine model for adjuvant treatment of renal cell carcinoma.
    Doehn C; Esser N; Pauels HG; Kiessig ST; Stelljes M; Grossmann A; Jocham D; Drevs J
    Eur Urol; 2009 Jul; 56(1):123-31. PubMed ID: 18550267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with interferon-alpha and interleukin-2.
    Sonouchi K; Hamilton TA; Tannenbaum CS; Tubbs RR; Bukowski R; Finke JH
    Am J Pathol; 1994 Apr; 144(4):747-55. PubMed ID: 8160774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy and MVA-MUC1-IL-2 vaccine act synergistically for inducing specific immunity to MUC-1 tumor antigen.
    Hillman GG; Reich LA; Rothstein SE; Abernathy LM; Fountain MD; Hankerd K; Yunker CK; Rakowski JT; Quemeneur E; Slos P
    J Immunother Cancer; 2017; 5():4. PubMed ID: 28116088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th2-like response and antitumor effect of anti-interleukin-4 mAb in mice bearing renal cell carcinoma.
    Takeuchi T; Ueki T; Sasaki Y; Kajiwara T; Li B; Moriyama N; Kawabe K
    Cancer Immunol Immunother; 1997 Jan; 43(6):375-81. PubMed ID: 9067410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.